HomeComparePFGTF vs CL

PFGTF vs CL: Dividend Comparison 2026

PFGTF yields 2928.26% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFGTF wins by $361025539516.68M in total portfolio value
10 years
PFGTF
PFGTF
● Live price
2928.26%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$361025539516.72M
Annual income
$338,299,201,707,171,140.00
Full PFGTF calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — PFGTF vs CL

📍 PFGTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPFGTFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PFGTF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PFGTF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PFGTF
Annual income on $10K today (after 15% tax)
$248,901.90/yr
After 10yr DRIP, annual income (after tax)
$287,554,321,451,095,460.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, PFGTF beats the other by $287,554,321,451,090,880.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PFGTF + CL for your $10,000?

PFGTF: 50%CL: 50%
100% CL50/50100% PFGTF
Portfolio after 10yr
$180512769758.38M
Annual income
$169,149,600,853,588,260.00/yr
Blended yield
93.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

PFGTF
No analyst data
Altman Z
-7.3
Piotroski
2/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PFGTF buys
0
CL buys
0
No recent congressional trades found for PFGTF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPFGTFCL
Forward yield2928.26%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$361025539516.72M$40.8K
Annual income after 10y$338,299,201,707,171,140.00$5,401.96
Total dividends collected$359452217273.28M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PFGTF vs CL ($10,000, DRIP)

YearPFGTF PortfolioPFGTF Income/yrCL PortfolioCL Income/yrGap
1← crossover$303,526$292,825.77$11,012$312.01+$292.5KPFGTF
2$8,631,330$8,306,557.62$12,196$412.95+$8.62MPFGTF
3$229,995,057$220,759,533.40$13,599$549.66+$229.98MPFGTF
4$5,743,736,775$5,497,642,063.87$15,288$736.64+$5743.72MPFGTF
5$134,458,222,494$128,312,424,145.27$17,353$995.28+$134458.21MPFGTF
6$2,951,098,829,728$2,807,228,531,659.88$19,926$1,357.80+$2951098.81MPFGTF
7$60,740,157,648,354$57,582,481,900,544.34$23,194$1,873.82+$60740157.63MPFGTF
8$1,172,632,305,361,387$1,107,640,336,677,648.80$27,439$2,621.52+$1172632305.33MPFGTF
9$21,239,568,046,309,668$19,984,851,479,572,984.00$33,088$3,727.38+$21239568046.28MPFGTF
10$361,025,539,516,722,500$338,299,201,707,171,140.00$40,806$5,401.96+$361025539516.68MPFGTF

PFGTF vs CL: Complete Analysis 2026

PFGTFStock

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, the company is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

Full PFGTF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this PFGTF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PFGTF vs SCHDPFGTF vs JEPIPFGTF vs OPFGTF vs KOPFGTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.